Time course of changes in the level of N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with rheumatoid arthritis during therapy with an interleukin-6 receptor inhibitor

Objective: to investigate the impact of therapy with the interleukin-6 receptor inhibitor tocilizumab (TCZ) on the time course of changes in N-terminal pro-brain  natriuretic  peptide (NT-proBNP) levels in patients with rheumatoid arthritis (RA) during a 12-month follow-up period.Subjects and method...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: E. V. Gerasimova, T. V. Popkova, A. V. Martynova, M. V. Cherkasova, D. S. Novikova
Format: Artigo
Sprache:Russo
Veröffentlicht: IMA-PRESS LLC 2019-11-01
Schriftenreihe:Научно-практическая ревматология
Schlagworte:
nt-probnp
rheumatoid arthritis
chronic heart failure
tocilizumab
Online Zugang:https://rsp.mediar-press.net/rsp/article/view/2783
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge